Discover how REAC technology supports neurobiological regulation in autism, helping individuals express their full potential and functional stability.

In recent years, the approach to autism has shifted from merely observing symptoms to understanding how individuals organize and regulate their neuropsychophysical resources. REAC® Technology stands at the forefront of this clinical evolution.
Autism is more than just challenges in communication or social interaction; it fundamentally involves how a person regulates stress, emotional responses, and attention. Many individuals struggle not because they lack potential, but because of the immense energy required to function when their internal regulation is fragile.
REAC neurobiological modulation protocols (such as NPO, NPPO, and NPPO CB) are designed to help the nervous system operate more efficiently. By targeting the “functional terrain,” these protocols help to:
A key takeaway is that REAC® technology is not an alternative to traditional psychological or educational therapies. Instead, it is a complementary tool. When a child is more regulated and less burdened by dysfunctional stress, they become more accessible to learning and social engagement, making all other interventions more effective.
Ultimately, embracing neurobiological regulation means offering a more comprehensive path toward personal growth and functional stability.
Watch the full video here:
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V